Sun Pharma announces leadership changes as Kirti Ganorkar steps down. Read the latest updates on the transition, company response, and what’s next for the pharmaceutical giant. Kirti Ganorkar Resigns as CEO of Sun Pharma’s India Business: Strategic Reshuffle Underway Introduction In a significant development for India’s pharmaceutical sector, Sun Pharmaceutical Industries Ltd. has announced the departure of Kirti Ganorkar, the Chief Executive Officer (CEO) of its India business. The move has generated considerable buzz in the industry, given Ganorkar’s deep association with Sun Pharma and his instrumental role in its domestic strategy. The announcement came through an official regulatory filing, wherein the company informed investors and stakeholders of Ganorkar’s resignation.…